283 related articles for article (PubMed ID: 15582078)
1. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.
Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
Ophthalmology; 2004 Dec; 111(12):2224-31. PubMed ID: 15582078
[TBL] [Abstract][Full Text] [Related]
2. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment.
Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
Ophthalmology; 2004 Dec; 111(12):2232-9. PubMed ID: 15582079
[TBL] [Abstract][Full Text] [Related]
3. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.
Jabs DA; Ahuja A; Van Natta M; Lyon A; Srivastava S; Gangaputra S;
Ophthalmology; 2010 Nov; 117(11):2152-61.e1-2. PubMed ID: 20673591
[TBL] [Abstract][Full Text] [Related]
4. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
Vrabec TR; Baldassano VF; Whitcup SM
Ophthalmology; 1998 Jul; 105(7):1259-64. PubMed ID: 9663231
[TBL] [Abstract][Full Text] [Related]
7. Visual field loss in patients with cytomegalovirus retinitis.
Thorne JE; Van Natta ML; Jabs DA; Duncan JL; Srivastava SK;
Ophthalmology; 2011 May; 118(5):895-901. PubMed ID: 21146225
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
Lin DY; Warren JF; Lazzeroni LC; Wolitz RA; Mansour SE
Retina; 2002 Jun; 22(3):268-77. PubMed ID: 12055458
[TBL] [Abstract][Full Text] [Related]
9. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-Term results in a small case series.
Reed JB; Briggs JW; McDonald JC; Freeman WR; Morse LS
Retina; 2001; 21(4):339-43. PubMed ID: 11508879
[TBL] [Abstract][Full Text] [Related]
10. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
Arevalo JF; Garcia RA; Mendoza AJ
Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
[TBL] [Abstract][Full Text] [Related]
11. Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.
Jabs DA; Ahuja A; Van Natta M; Dunn JP; Yeh S;
Ophthalmology; 2013 Jun; 120(6):1262-70. PubMed ID: 23419804
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical activity of CMV retinitis in patients receiving highly active antiretroviral therapy.
Song MK; Schrier RD; Smith IL; Plummer DJ; Freeman WR
Retina; 2002 Jun; 22(3):262-7. PubMed ID: 12055457
[TBL] [Abstract][Full Text] [Related]
13. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
Retina; 2000; 20(2):151-5. PubMed ID: 10783947
[TBL] [Abstract][Full Text] [Related]
14. Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort.
Jabs DA; Ahuja A; Van Natta ML; Lyon AT; Yeh S; Danis R;
Ophthalmology; 2015 Jul; 122(7):1452-63. PubMed ID: 25892019
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment.
Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
Ophthalmology; 2007 Apr; 114(4):780-6. PubMed ID: 17258320
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy.
Jabs DA; Van Natta ML; Holland GN; Danis R;
Am J Ophthalmol; 2017 Feb; 174():23-32. PubMed ID: 27984023
[TBL] [Abstract][Full Text] [Related]
17. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
Macdonald JC; Karavellas MP; Torriani FJ; Morse LS; Smith IL; Reed JB; Freeman WR
Ophthalmology; 2000 May; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
[TBL] [Abstract][Full Text] [Related]
18. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Sugar EA; Jabs DA; Ahuja A; Thorne JE; Danis RP; Meinert CL;
Am J Ophthalmol; 2012 Jun; 153(6):1016-24.e5. PubMed ID: 22310076
[TBL] [Abstract][Full Text] [Related]
19. Assessment of cytomegalovirus retinitis. Clinical evaluation vs centralized grading of fundus photographs. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jul; 114(7):791-805. PubMed ID: 8660161
[TBL] [Abstract][Full Text] [Related]
20. Incidence Rate and Risk Factors for Contralateral Eye Involvement among Patients with AIDS and Cytomegalovirus Retinitis Treated with Local Therapy.
Sittivarakul W; Benjhawaleemas T; Aui-Aree N; Jirarattanasopa P; Liabsuetrakul T
Ocul Immunol Inflamm; 2016 Oct; 24(5):530-6. PubMed ID: 26327465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]